These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 28601382)

  • 61. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sentinel node biopsy in early breast cancer: lessons learned from more than 1000 cases at a single institution.
    Fancellu A; Cottu P; Feo CF; Bertulu D; Giuliani G; Mulas S; Sanna V; Mura S; Madeddu G; Spanu A
    Tumori; 2012; 98(4):413-20. PubMed ID: 23052155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
    Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
    Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.
    Vriens BEPJ; Keymeulen KBMI; Kroep JR; Charehbili A; Peer PG; de Boer M; Aarts MJB; Heuts EM; Tjan-Heijnen VCG;
    Oncotarget; 2017 Jul; 8(28):46557-46564. PubMed ID: 28177921
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Wang J; Fan T; He Y; Chen X; Fan Z; Xie Y; Wang T; Li J; Ouyang T
    Breast Cancer Res Treat; 2018 Apr; 168(2):365-370. PubMed ID: 29209873
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Review of the role of the sentinel node biopsy in neoadjuvant chemotherapy in women with breast cancer and negative or positive axillary node at diagnosis.
    Ruano Pérez R; Rebollo Aguirre AC; García-Talavera San Miguel P; Díaz Expósito R; Vidal-Sicart S; Cordero García JM; Carrera Salazar D; Rioja Martín ME;
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):63-70. PubMed ID: 28869178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Fernandez-Gonzalez S; Falo C; Pla MJ; Pernas S; Bajen M; Soler T; Ortega R; Quetglas C; Perez-Martin X; Fernandez Montoli ME; Campos M; Varela-Rodriguez M; Ponce J; Garcia-Tejedor A
    Clin Breast Cancer; 2018 Feb; 18(1):71-77. PubMed ID: 29030106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
    Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
    Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy.
    Kinoshita T
    Breast Cancer; 2007; 14(1):10-5. PubMed ID: 17244988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The prognostic impact of mode of detection of axillary metastases for women with invasive breast cancer: A retrospective observational study.
    McNeil K; Macaskill EJ; Purdie C; Evans A
    Eur J Surg Oncol; 2021 Apr; 47(4):813-817. PubMed ID: 33153822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
    El Hage Chehade H; Headon H; El Tokhy O; Heeney J; Kasem A; Mokbel K
    Am J Surg; 2016 Nov; 212(5):969-981. PubMed ID: 27671032
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.
    Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H
    Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Axillary sentinel node biopsy after neoadjuvant chemotherapy.
    Ozmen V; Unal ES; Muslumanoglu ME; Igci A; Canbay E; Ozcinar B; Mudun A; Tunaci M; Tuzlali S; Kecer M
    Eur J Surg Oncol; 2010 Jan; 36(1):23-9. PubMed ID: 19931375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.